Tobacco Products
FDA’s Center for Tobacco Products (CTP) works to ensure a healthier life for every family.
Latest Updates from the Center for Tobacco Products
FDA Warns Five More Retailers for Selling Unauthorized E-Cigarettes
The warning letters cite the sale of products marketed under popular brand names such as Elf Bar/EB Design/EB Create, Funky Republic, Lost Mary, Hyde, Breeze, and Cali Bars
FDA Files Complaints Seeking Maximum Fines Against 20 More Retailers for Sellin…
FDA Issues Fines for Retailers Selling Unauthorized E-Cigarettes
FDA’s Progress on Tobacco Product Regulation in 2023
As CTP continues to focus on the year ahead, Director Brian King publishes a statement to acknowledge the center’s many accomplishments throughout 2023
Tobacco Product Marketing Granted Orders (MGO)
To date, the FDA has authorized 23 tobacco-flavored e-cigarette products and devices. These are the only e-cigarette products that currently may be lawfully sold in the U.S. The distribution or sale of unlawfully marketed products is subject to enforcement action.
See the Legal E-Cigarette Products to Sell and Other MGOsCTP Strategic Plan
On Dec. 18, 2023, CTP released a new 5-year strategic plan. The plan defined five goals, reinforced by four cross-cutting themes, 10 outcomes, and several corresponding objectives. CTP also reviewed and refreshed its vision and mission statements.
View CTP’s Strategic PlanContact CTP
1-877-287-1373 (9am - 4pm ET)
For General Inquiries: AskCTP@fda.hhs.gov
Center for Tobacco Products
Food and Drug Administration
10903 New Hampshire Avenue
Document Control Center
Building 71, Room G335
Silver Spring, MD 20993-0002